Transcriptomic deconvolution reveals prognostic immune signatures and immunotherapy-responsive subtypes in male breast cancer
Valentina Silvestri(Cancer Research UK Cambridge Center), Laura Ottini(Mount Sinai Hospital), Giuseppe Giannini(Istituto Pasteur), Bruna Cerbelli(Sapienza University of Rome), Valentina Arcangeli, Ines Zanna(Piedmont Reference Center for Epidemiology and Cancer Prevention), Simonetta Bianchi(University of Florence), Silvia Mezi(Policlinico Umberto I), Agostino Bucalo(Sapienza University of Rome), Giulia d’Amati(Sapienza University of Rome), Virginia Porzio(Sapienza University of Rome), Giovanna Masala(Piedmont Reference Center for Epidemiology and Cancer Prevention), Laura Cortesi(Azienda Ospedaliero-Universitaria di Modena), Carlo Capalbo(Sapienza University of Rome), Daniele Calistri(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giorgia Scafetta(Azienda Ospedaliera Sant'Andrea), Virginia Valentini(Sapienza University of Rome), Elisa Gasparini(Azienda Sanitaria Unità Locale di Reggio Emilia), Stephen B. Fox(Peter MacCallum Cancer Centre), Ileana Carnevali(University of Insubria), Maria Grazia Tibiletti(University of Insubria), Valentina Zampiga(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 0
Related Papers
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
|The Lancet Oncology|2012|1.3k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
|The Lancet Oncology|2015|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k